Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China flag China · Delayed Price · Currency is CNY
12.92
+0.31 (2.46%)
Aug 20, 2026, 3:00 PM CST

SHA:603439 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
200.33389.69476.07571.37570.88544.22
Trading Asset Securities
175.9619.9322.9551.559.9198
Cash & Short-Term Investments
376.3409.61499.02622.87630.79642.22
Cash Growth
-10.24%-17.92%-19.89%-1.26%-1.78%10.72%
Accounts Receivable
878.55858.34932.12682.86432.82312.8
Other Receivables
2.54-0.382.533.322.1851.41
Receivables
881.08857.95934.65686.18435.01364.21
Inventory
207.19222.42320.72175.7298.0888.57
Other Current Assets
34.2339.643.598.698.184.55
Total Current Assets
1,4991,5301,7981,4931,1721,100
Property, Plant & Equipment
543.04545.57585.15615.13237.4157.91
Long-Term Investments
89.3989.622.5510.08129.77119.13
Goodwill
432.63432.63554.61554.61161.66-
Other Intangible Assets
189.62194.28216.13235.23107.320.38
Long-Term Deferred Tax Assets
17.215.7915.1311.086.895.12
Long-Term Deferred Charges
0.570.660.560.861.542.9
Other Long-Term Assets
39.4739.81----
Total Assets
2,8112,8483,1922,9201,8171,405

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
111.64101.11342.73247.98165.2698.84
Accrued Expenses
12.5578.6867.3339.4831.3316.59
Short-Term Debt
498.32548.67351.52255.32205200
Current Portion of Long-Term Debt
60.0259.845.1545.22--
Current Portion of Leases
-0.110.50.150.5-
Current Income Taxes Payable
40.4510.5113.8412.7710.919.4
Current Unearned Revenue
4.175.477.798.1778.965.83
Other Current Liabilities
226.75232.82405.59229.9256.7229.76
Total Current Liabilities
953.891,0371,234839.01548.68360.42
Long-Term Debt
149.5149.72209.3254.15--
Long-Term Leases
-0.030.210.170.17-
Long-Term Unearned Revenue
38.1739.1942.9735.9712.512.5
Long-Term Deferred Tax Liabilities
21.1421.9925.528.886.94-
Other Long-Term Liabilities
87.3587.5985.0452.9210.1-
Total Liabilities
1,2501,3361,5971,211578.4372.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
408.93408.93409.8409.86410.86410.86
Additional Paid-In Capital
156.47153.26149.04225.12229.69223.39
Retained Earnings
1,022977.751,069876.75625.04423.75
Treasury Stock
-94.35-94.35-100.64-41.43-26.55-26.55
Total Common Equity
1,4931,4461,5271,4701,2391,031
Minority Interest
67.4666.6367.29239.04-0.820.61
Shareholders' Equity
1,5611,5121,5951,7091,2381,032
Total Liabilities & Equity
2,8112,8483,1922,9201,8171,405

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
707.84758.32606.68555.02205.67200
Net Cash (Debt)
-331.54-348.71-107.6767.86425.12442.22
Net Cash Growth
----84.04%-3.87%16.36%
Net Cash Per Share
-0.80-0.83-0.260.161.031.07
Filing Date Shares Outstanding
404.74404.74405.61408.25410.86410.86
Total Common Shares Outstanding
404.74404.74405.61408.25410.86410.86
Working Capital
544.91492.42563.53654.46623.38739.12
Book Value Per Share
3.693.573.773.603.022.51
Tangible Book Value
870.96818.69756.61680.48970.091,011
Tangible Book Value Per Share
2.152.021.871.672.362.46
Buildings
-502.56543.28549.09181.14152.85
Machinery
-352.81351.45344.91103.2758.44
Construction In Progress
---0.0448.594.17